Blood eosinophil counts as a guide for COPD treatment strategies
- PMID: 29331310
- DOI: 10.1016/S2213-2600(18)30005-5
Blood eosinophil counts as a guide for COPD treatment strategies
Comment on
-
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10. Lancet Respir Med. 2018. PMID: 29331313 Clinical Trial.